The Cadent Therapeutics brand, founded in 2010 (United States), from 2951 sister brands and 17477 competing brands. Cadent Therapeutics is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. Cadent Therapeutics is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(Cadent Therapeutics)
over 5 years*
CHF 93.85